Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.
Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
Owlet Baby Care offers a health monitor that allows parents to view their child's vital signs in real-time.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
CesiumAstro provides out-of-the-box communication systems for satellites, UAVs, launch vehicles, and other space or airborne platforms.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Janus Henderson Investors has invested in 227 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Medical, Life Science, Therapeutics, Health Care. The firm invests across 23 different industry categories.
Among tracked funding rounds, Vaxcyte received $632.5M in a Post Ipo Equity round. Janus Henderson Investors's total known invested capital is $35.8B.
Janus Henderson Investors's average investment size is $153.6M across its portfolio of 227 companies.
Recent Janus Henderson Investors portfolio additions include Thrive Earlier Detection, Shoreline Biosciences, Nuvalent, Metsera, Centessa Pharmaceuticals. These companies were founded in 2020 or later.